HSBC Holdings
KRTX

HSBC Holdings’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

HSBC Holdings’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64,557
Closed -$20.4M – 3281
2023
Q4 		$20.4M Buy
64,557
+52,557
+438% +$10.2M 0.02% 666
2023
Q3 		$2.03M Buy
+12,000
New +$2.26M ﹤0.01% 1447
2022
Q4 		– Sell
-2,644
Closed -$603K – 3227
2022
Q3 		$603K Sell
2,644
-5,959
-69% -$1.21M ﹤0.01% 2082
2022
Q2 		$1.09M Sell
8,603
-152
-2% -$17.5K ﹤0.01% 1881
2022
Q1 		$1.11M Buy
8,755
+1,469
+20% +$165K ﹤0.01% 1881
2021
Q4 		$954K Buy
+7,286
New +$942K ﹤0.01% 2083
2019
Q4 		– Sell
-31,168
Closed -$509K – 3229
2019
Q3 		$509K Buy
+31,168
New +$606K ﹤0.01% 2326

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

HSBC Holdings's KRTX Position: Q1 2024 in Review

HSBC Holdings sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 64,557 shares — an estimated $20.4M sold.

HSBC Holdings first reported a position in KRTX in Q3 2019 and held it in 7 quarters. The position peaked at $20.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • HSBC Holdings reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • HSBC Holdings sold 64,557 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $20.4M.
  • HSBC Holdings first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
  • HSBC Holdings's Karuna Therapeutics, Inc. Common Stock position peaked at $20.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.